Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
Public Policy
Share |

Throughout 2016, Life Science Washington will focus on smaller, personal engagements with legislators and policy makers.

 

 

To help us implement this more personal approach, please send us an email if you have a personal relationship with a member of the legislature so that we can include you in those conversations. Likewise, if you or your company would like to host a round-table discussion at your facility, please let us know and we will get in touch with you to coordinate the details. Life Science Washington will handle everything! You just need to do what you do best — show how your company is developing products that improve people’s lives!


If you would like to be part of this year’s engagement strategy, please email Marc Cummings, your Vice President of Public Policy & External Affairs at marc@washbio.org

 


 

 

Drug Pricing is in the News; Here's What You Should Know

 

Recently, news and political discourse about the healthcare and pharmaceutical industry has been dominated by discussions about the cost of drugs.  As we enter a Presidential election year, it is likely that drug costs and pricing will continue to be front and center. To address this issue, the Biotechnology Industry Association (BIO) drafted a white paper designed to help people better understand the innovative work we do and the risk that is undertaken to bring life-saving cures and innovative therapies to market. If you are interested in receiving the full white paper titled, “Unleashing the Next Generation of Biotechnology Innovation,” please email marc.cummings@washbio.org

 

more Calendar

8/18/2016
2016 Summer Social Round-up

9/19/2016
2016 Golf Invitational - Individual & Foursome Golfer Registration

Featured Partners
BioTech Primer Inc.BioTech Primer develops and delivers customized training to the Life Sciences community

Membership Management Software Powered by YourMembership.com®  ::  Legal